Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.735 -0.035 (-1.26%)

Streaming Delayed Price Updated: 1:08 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference

September 07, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List ↗

August 28, 2023

Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.

Via InvestorPlace

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

August 18, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Expert Ratings for Iovance Biotherapeutics ↗

August 09, 2023

Via Benzinga

Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate Updates

August 08, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Cathie Wood Continues Iridium Shopping Spree — Ark Invest Buys $3.6M Worth Of Satellite Company's Stock ↗

August 02, 2023

Via Benzinga

Cathie Wood Buys $3.4M Worth Of Shares In This Payments Software Firm — Also Increases Exposure To Iridium Stock ↗

August 01, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells Robinhood, Coinbase Shares — Buys $3.5M Worth Of Stock Of This Social Media Company ↗

July 31, 2023

Via Benzinga

7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick ↗

July 31, 2023

For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.

Via InvestorPlace

Cathie Wood's Ark Invest Continues To Sell Shares Of Warren Buffett-Backed BYD — Coinbase Holdings Trimmed As Well ↗

July 26, 2023

Via Benzinga

Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer

July 25, 2023

Oral Presentation of Cohort 3A Data from IOV-COM-202 Phase 2 Clinical Trial of LN-145 in Combination with Pembrolizumab in Anti-PD1-naïve Advanced (metastatic or unresectable) Non-Small Cell Lung...

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, August 8, 2023

July 24, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

July 21, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Announces Closing of $172.5 Million Common Stock Public Offering

July 13, 2023

Offering Includes Exercise in Full of the Underwriters’ Option to Purchase an Additional 3 Million Shares of Common Stock

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.

Via Benzinga

Why Iovance Biotherapeutics Stock Is Dropping Tuesday ↗

July 11, 2023

The company is doing a $150 million public stock offering.

Via The Motley Fool

DNA Stock Alert: Ginkgo Bioworks Moves Forward With Novo Nordisk Partnership ↗

July 11, 2023

Ginkgo Bioworks (DNA) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk.

Via InvestorPlace

Why Is Zillow (Z) Stock Up 8% Today? ↗

July 11, 2023

Zillow (Z) stock is on the rise Tuesday after the tech real-estate marketplace company's shares got an upgrade from Piper Sandler.

Via InvestorPlace

Why Is Iovance Biotherapeutics (IOVA) Stock Down 10% Today? ↗

July 11, 2023

Iovance Biotherapeutics (IOVA) stock is sliding lower on Tuesday after the company announced details of a public share offering.

Via InvestorPlace

Why Iovance Biotherapeutics Shares Are Tumbling Tuesday ↗

July 11, 2023

Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading lower Tuesday after the company announced the pricing of a public o

Via Benzinga

Why These 2 Nasdaq Biotech Stocks Fell Hard Tuesday Morning ↗

July 11, 2023

Broader markets seemed likely to start out on a positive note despite these two outliers.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 11, 2023

Via Benzinga

Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 11, 2023

It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday!

Via InvestorPlace

JetBlue Airways, VOXX International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 11, 2023

U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

WD-40, VOXX International And 3 Stocks To Watch Heading Into Tuesday ↗

July 11, 2023

With U.S. stock futures trading slightly higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $150 Million of Common Stock

July 10, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Fisker, Iovance Biotherapeutics Lead Gains — Tesla Dips: Top 5 Trending Stocks Today ↗

July 10, 2023

Via Benzinga

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

July 10, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance's Update Provides Reassurance With Upcoming Lifileucel's FDA Action Date, Analyst Says ↗

July 10, 2023

Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced regulatory and clinical updates related to its registrational single-arm Phase 2 IOV-LUN-202 trial in post-anti-PD-1

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.